But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...

They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...

Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart ...

Weight-loss injection Mounjaro, also known as tirzepatide, will be rolled out on the NHS gradually over a 12-year period. The ...

For the state, the cost of funding GLP-1 drugs was too high. For the patients, the cost of losing access is higher.

Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...

Losing weight can be a challenge for many. With so many variables present in everyday life, including stress, lack of sleep, ...

A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...

As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a ...

Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for eligible patients in England. It could take up to 12 years for everyone ...

The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.